Product
SSS40
1 clinical trial
1 indication
Indication
HealthyClinical trial
SSS40 A Single-center, Randomized, Double-blind, Placebo-controlled Phase I Clinical Study of Single-dose, Dose-escalation Safety, Tolerability, Pharmacokinetics, and Immunogenicity in Healthy Chinese Subjects.Status: Not yet recruiting, Estimated PCD: 2023-10-26